Johnson & Johnson has pulled back from last week's cycle high, but the fundamental setup has not materially changed: short interest remains near a one-year low, the Street is broadly constructive, and the spinoff overhang is becoming a known quantity rather than a surprise. The stock closed at $266.17 on November 3, down 1.6% on the day and off 1% for the week, reversing part of the…
JNJ short interest falls to 0.65% of free float, down 20% in a week as short sellers exit positions ahead of stronger pipeline data and analyst upgrades.
Key data as of 5 Nov 2026
JNJ short interest falls to 0.65% of free float, down 20% in a week as short sellers exit positions ahead of stronger pipeline data and analyst upgrades.
A new long-form analysis for JNJ this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumJohnson & Johnson heads into Tuesday's Q2 print having given back a chunk of its recent rally, with the stock now trading below even the updated analyst consensus mean. The price reversal is the sharpest development…
Johnson & Johnson has moved further ahead of consensus this week, with the stock now trading above even the most recently upgraded analyst targets and Q2 earnings just six days away. The Street played catch-up on…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for JNJ — free to start on ORTEX.
Sign up for free →Open JNJ on ORTEX